Y Kawamura

659 total citations
17 papers, 538 citations indexed

About

Y Kawamura is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Y Kawamura has authored 17 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Hematology. Recurrent topics in Y Kawamura's work include Kawasaki Disease and Coronary Complications (7 papers), Helicobacter pylori-related gastroenterology studies (5 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Y Kawamura is often cited by papers focused on Kawasaki Disease and Coronary Complications (7 papers), Helicobacter pylori-related gastroenterology studies (5 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Y Kawamura collaborates with scholars based in Japan. Y Kawamura's co-authors include S Takeshita, Kazuhiko Nakatani, Isao Sekine, Tomoharu Tokutomi, Hiroshi Tsujimoto, Tomoari Kamada, Ken Haruma, Kazuaki Chayama, Shinji Tanaka and Hiroaki Kusunoki and has published in prestigious journals such as Gastroenterology, Alimentary Pharmacology & Therapeutics and Journal of the Neurological Sciences.

In The Last Decade

Y Kawamura

15 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y Kawamura Japan 11 372 276 92 76 66 17 538
J. J. Kolkman Netherlands 8 332 0.9× 161 0.6× 58 0.6× 196 2.6× 32 0.5× 17 785
Shoki Mikata Japan 13 275 0.7× 188 0.7× 45 0.5× 39 0.5× 16 0.2× 48 465
Eugenio Ciancia Italy 12 152 0.4× 117 0.4× 76 0.8× 37 0.5× 46 0.7× 39 609
Michael D. Kelly United Kingdom 12 411 1.1× 210 0.8× 40 0.4× 25 0.3× 21 0.3× 30 588
J. D. Wig India 15 498 1.3× 238 0.9× 76 0.8× 85 1.1× 60 0.9× 29 773
Selim Aydemir Türkiye 13 304 0.8× 155 0.6× 29 0.3× 96 1.3× 23 0.3× 46 542
Aykut Ferhat Çelık Türkiye 15 170 0.5× 154 0.6× 75 0.8× 74 1.0× 10 0.2× 51 594
Marko Nikolić Croatia 14 356 1.0× 508 1.8× 234 2.5× 25 0.3× 52 0.8× 61 843
R. Urgesi Italy 15 286 0.8× 77 0.3× 52 0.6× 70 0.9× 46 0.7× 49 549
E Quintanilla Spain 16 261 0.7× 192 0.7× 45 0.5× 111 1.5× 13 0.2× 52 681

Countries citing papers authored by Y Kawamura

Since Specialization
Citations

This map shows the geographic impact of Y Kawamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Kawamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Kawamura more than expected).

Fields of papers citing papers by Y Kawamura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y Kawamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Kawamura. The network helps show where Y Kawamura may publish in the future.

Co-authorship network of co-authors of Y Kawamura

This figure shows the co-authorship network connecting the top 25 collaborators of Y Kawamura. A scholar is included among the top collaborators of Y Kawamura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y Kawamura. Y Kawamura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Matsuo, Hirotaka, Hiroyuki Tomiyama, Wataru Satake, et al.. (2015). Onset age of Parkinson’s disease is delayed by a common dysfunctional variant of ABCG2, a major causative gene for early-onset gout. Journal of the Neurological Sciences. 357. e279–e279.
2.
Kamada, Tomoari, Jiro Hata, Hiroaki Kusunoki, et al.. (2005). Effect of long‐term half‐dose famotidine therapy on corpus gastritis in peptic ulcer disease. Alimentary Pharmacology & Therapeutics. 21(s2). 99–104. 3 indexed citations
3.
Kamada, Tomoari, Jiro Hata, Hiroaki Kusunoki, et al.. (2005). Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori: results from a 9‐year prospective follow‐up study in Japan. Alimentary Pharmacology & Therapeutics. 21(9). 1121–1126. 115 indexed citations
4.
Takeshita, S, et al.. (2005). Imbalance in the production between vascular endothelial growth factor and endostatin in Kawasaki disease. Clinical & Experimental Immunology. 139(3). 575–579. 17 indexed citations
5.
Kamada, Tomoari, Jiro Hata, Hiroaki Kusunoki, et al.. (2004). Eradication of Helicobacter pylori increases the incidence of hyperlipidaemia and obesity in peptic ulcer patients. Digestive and Liver Disease. 37(1). 39–43. 64 indexed citations
6.
Nakatani, Kazuhiko, S Takeshita, Hiroshi Tsujimoto, et al.. (2003). Circulating endothelial cells in Kawasaki disease. Clinical & Experimental Immunology. 131(3). 536–540. 79 indexed citations
7.
Takeshita, S, I Kobayashi, Y Kawamura, Tomoharu Tokutomi, & Isao Sekine. (2002). Characteristic profile of intestinal microflora in Kawasaki disease. Acta Paediatrica. 91(7). 783–788. 21 indexed citations
8.
Takeshita, S, Tomoharu Tokutomi, Kazuhiko Nakatani, et al.. (2001). Elevated serum levels of matrix metalloproteinase-9 (MMP-9) in Kawasaki disease. Clinical & Experimental Immunology. 125(2). 340–344. 66 indexed citations
9.
Tsujimoto, Hiroshi, S Takeshita, Kazuhiko Nakatani, et al.. (2001). Delayed apoptosis of circulating neutrophils in Kawasaki disease. Clinical & Experimental Immunology. 126(2). 355–364. 46 indexed citations
10.
Kamada, Tomoari, Ken Haruma, Eiji Miyoshi, et al.. (2000). Cetraxate, a mucosal protective agent, combined with omeprazole, amoxycillin, and clarithromycin increases the eradication rate of Helicobacter pylori in smokers. Alimentary Pharmacology & Therapeutics. 14(8). 1089–1094. 20 indexed citations
11.
Tsujimoto, Hironori, S Takeshita, Y Kawamura, Kazuhiko Nakatani, & Masaaki Sato. (2000). Isolated Congenital Left Ventricular Diverticulum with Perinatal Dysrhythmia: A Case Report and Review of the Literature. Pediatric Cardiology. 21(2). 175–179. 23 indexed citations
12.
Takeshita, S, et al.. (2000). Increased levels of circulating soluble CD14 in Kawasaki disease. Clinical & Experimental Immunology. 119(2). 376–381. 41 indexed citations
13.
Iwasaki, A., Noriko Nakajima, Keisuke Kato, et al.. (1998). Study of the usefulness of measurement of serum pepsinogen in eradication therapy of Helicobacter pylori. Gastroenterology. 114. A159–A159. 4 indexed citations
14.
Takeshita, S, Hiroshi Dobashi, Kazuhiko Nakatani, et al.. (1997). Circulating soluble selectins in Kawasaki disease. Clinical & Experimental Immunology. 108(3). 446–450. 32 indexed citations
15.
Kobayashi, Yoshio, Motoki Kino, Hirohiko Higashino, et al.. (1996). [Clinical study of a macrolide antibiotic, azithromycin, in pediatric patients].. PubMed. 49(11). 1004–12. 1 indexed citations
16.
Morita, Kazutoyo, Jun Fukuzawa, Sokichi Onodera, et al.. (1992). Hemoglobin Kansas found in a patient with polycythemia. Annals of Hematology. 65(5). 229–231. 4 indexed citations
17.
Izumi, Hideki, et al.. (1969). Thalassemia intermedia complicated by hemochromatosis: clinical and autopsy report of a case.. PubMed. 32(2). 336–52. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. J. Kolkman Breakdown of academic impact, for papers by Shoki Mikata Breakdown of academic impact, for papers by Eugenio Ciancia Breakdown of academic impact, for papers by Michael D. Kelly Breakdown of academic impact, for papers by J. D. Wig Breakdown of academic impact, for papers by Selim Aydemir Breakdown of academic impact, for papers by Aykut Ferhat Çelık Breakdown of academic impact, for papers by Marko Nikolić Breakdown of academic impact, for papers by R. Urgesi Breakdown of academic impact, for papers by E Quintanilla
Rankless by CCL
2026